CCL21-induced immune cell infiltration

International Immunopharmacology

Volumn 7, Issue 2, 2007, Pages 272-276

  Ashour, Abdelkader E ^a,b   Turnquist, Heth R ^a,b   Singh, Rakesh K ^a   Talmadge, James E ^a   Solheim, Joyce C ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

CCL21; Chemokines; Dendritic cell; T lymphocyte; Vaccine

Indexed keywords

SECONDARY LYMPHOID TISSUE CHEMOKINE; VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CELL INFILTRATION; CONTROLLED STUDY; DENDRITIC CELL; EFFECTOR CELL; FEMALE; IMMUNOCOMPETENT CELL; LYMPH NODE; LYMPHATIC DRAINAGE; LYMPHOID CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; CHEMOKINES, CC; DENDRITIC CELLS; FEMALE; LYMPH NODES; MICE; MICE, INBRED C57BL; SKIN; T-LYMPHOCYTES, CYTOTOXIC;

EID: 33845945960     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2006.10.004     Document Type: Article

References (43)

1. Robertson M.J. Role of chemokines in the biology of natural killer cells. J Leukoc Biol 71 (2002) 173-183
2. Vitale M., Della Chiesa M., Carlomagno S., Romagnani C., Thiel A., Moretta L., et al. The small subset of CD56brightCD16-natural killer cells is selectively responsible for both cell proliferation and interferon-gamma production upon interaction with dendritic cells. Eur J Immunol 34 (2004) 1715-1722
3. Cyster J.G. Chemokines and cell migration in secondary lymphoid organs. Science 286 (1999) 2098-2102
4. Willimann K., Legler D.F., Loetscher M., Roos R.S., Delgado M.B., Clark-Lewis I., et al. The chemokine SLC is expressed in T cell areas of lymph nodes and mucosal lymphoid tissues and attracts activated T cells via CCR7. Eur J Immunol 28 (1998) 2025-2034
5. Fan L., Reilly C.R., Luo Y., Dorf M.E., and Lo D. Cutting edge: ectopic expression of the chemokine TCA4/SLC is sufficient to trigger lymphoid neogenesis. J Immunol 164 (2000) 3955-3959
6. Sanchez-Sanchez N., Riol-Blanco L., de la Rosa G., Puig-Kroger A., Garcia-Bordas J., Marin D., et al. Chemokine receptor CCR7 induces intracellular signaling that inhibits apoptosis of mature dendritic cells. Blood 104 (2004) 619-625
7. Wornle M., Schmid H., Merkle M., and Banas B. Effects of chemokines on proliferation and apoptosis of human mesangial cells. BMC Nephrol 5 (2004) 8-21
8. Yanagawa Y., and Onoe K. CCR7 ligands induce rapid endocytosis in mature dendritic cells with concomitant up-regulation of Cdc42 and Rac activities. Blood 101 (2003) 4923-4929
9. Vacari A.P., Ait-Yahi S., Chemin K., Mueller A., Zlotnik A., and Caux C. Antitumor effects of the mouse chemokine 6Ckine/SLC through angiostatic and immunological mechanisms. J Immunol 165 (2000) 1992-2000
10. Mayordomo J.I., Zorina T., Storkus W.J., Zitvogel L., Celluzzi C., Falo L.D., et al. Bone marrow-derived dendritic cells pulsed with synthetic tumor peptides elicit protective and therapeutic antitumour immunity. Nat Med 1 (1995) 1297-1302
11. Gallo O., Libonati G.A., Gallina E., Fini-Storchi O., Giannini A., Urso C., et al. Langerhans cells related to pronosis in patients with laryngeal carcinoma. Arch Otolaryngol Head Neck Surg 117 (1991) 1007-1010
12. Ambe K., Mori M., and Enjoji M. S-100 protein-positive dendritic cells in colorectal adenocarcinomas. Distribution and relation to the clinical prognosis. Cancer 63 (1989) 496-503
13. Zeid N.A., and Muller H.K. S100 positive dendritic cells in human lung tumors associated with cell differentiation and enhanced survival. Pathology 25 (1993) 338-343
14. Tsujitani S., Kakeji Y., Maehara Y., Sugimachi K., and Kaibara N. Dendritic cells prevent lymph node metastasis in patients with gastric cancer. In Vivo 7 (1993) 233-237
15. Kakeji Y., Maehara Y., Korenaga D., Tsujitani S., Haraguchi M., Watanabe A., et al. Prognostic significance of tumor-host interaction in clinical gastric cancer: relationship between DNA ploidy and dendritic cell infiltration. J Surg Oncol 52 (1993) 207-212
16. Schroder S., Schwarz W., Rehpenning W., Loning T., and Bocker W. Dendritic/Langerhans cells and prognosis in patients with papillary thyroid carincomas. Immunocytochemical study of 106 thyroid neoplasms correlated to follow-up data. Am J Clin Pathol 89 (1988) 295-300
17. Alavaikko M., Blanco G., Aine R., Lehtinen T., Fellbaum C., Taskinen P., et al. Follicular dendritic cells have prognostic relevance in hodgkin's disease. Am J Clin Pathol 101 (1994) 761-767
18. Bethwaite P., Holloway L., Thornton A., and Delahunt B. Infiltration by immunocompetent cells in early sage invasive carcinoma of the uterine cervix: a prognostic study. Pathology 28 (1996) 321-327
19. Goldman S.A., Baker E., Weyant R.J., Clarke M.R., Myers J.N., and Lotze M.T. Peritumoral CD1a-positive dendritic cells are associated with improved survival in patients with tongue carcinoma. Arch Otolaryngol Head Neck Surg 124 (1998) 641-646
20. Okano F., Merad M., Furumoto K., and Engleman E.G. In vivo manipulation of dendritic cells overcomes tolerance to unmodified tumor-associated self antigens and induces potent antitumor immunity. J Immunol 174 (2005) 2645-2652
21. Kirk C.J., Hartigan-O'Connor D., and Mule J.J. The dynamics of the T-cell antitumor response: chemokine-secreting dendritic cells can prime tumor-reactive T cells extranodally. Cancer Res 61 (2001) 8794-8802
22. Kirk C.J., Hartigan-O'Connor D., Nickoloff B.J., Chamberlain J.S., Giedlin M., Aukerman L., et al. T cell-dependent antitumor immunity mediated by secondary lymphoid tissue chemokine: augmentation of dendritic cell-based immunotherapy. Cancer Res 61 (2001) 2062-2070
23. Sharma A., Stolina M., Luo J., Strieter R.M., Burdick M., Zhu L.X., et al. Secondary lymphoid tissue chemokine mediates T cell-dependent antitumor responses in vivo. J Immunol 164 (2000) 4558-4563
24. Sharma S., Stolina M., Zhu L., Lin Y., Batra R., Huang M., et al. Secondary lymphoid organ chemokine reduces pulmonary tumor burden in spontaneous murine bronchoalveolar cell carcinoma. Cancer Res 61 (2001) 6406-6412
25. Sharma S., Yang S.C., Hillinger S., Zhu L.X., Huang M., Batra R.K., et al. SLC/CCL21-mediated anti-tumor responses require IFNgamma, MIG/CXCL9 and IP-10/CXCL10. Mol Cancer 2 (2003) 22-27
26. Yang S.C., Hillinger S., Riedl K., Zhang L., Zhu L., Huang M., et al. Intratumoral administration of dendritic cells overexpressing CCL21 generates systemic antitumor responses and confers tumor immunity. Clin Cancer Res 10 (2004) 2891-2901
27. Toka F.N., Gierynska M., and Rouse B.T. Codelivery of CCR7 ligands as molecular adjuvants enhances the protective immune response against herpes simplex virus type I. J Virol 77 (2003) 12742-12752
28. Morelli A.E., and Thomson A.W. Dendritic cells: regulators of alloimmunity and opportunities for tolerance induction. Immunol Rev 196 (2003) 125-146
29. +DC1 precursors. Blood 101 (2003) 1453-1459
30. Whiteside T.L., and Odoux C. Dendritic cell biology and cancer therapy. Cancer Immunol Immunother 53 (2004) 240-248
31. + tumor-infiltrating lymphocytes. J Exp Med 173 (1991) 647-658
32. Le H.N., Lee N.C., Tsung K., and Norton J.A. Pre-existing tumor-sensitized T cells are essential for eradication of established tumors by IL-12 and cyclophosphamide plus IL-12. J Immunol 167 (2001) 6765-6772
33. Grufman P., and Karre K. Innate and adaptive immunity to tumors: IL-12 is required for optimal responses. Eur J Immunol 30 (2000) 1088-1093
34. Hill H.C., Conway Jr. T.F., Sabel M.S., Jong Y.S., Mathiowitz E., Bankert R.B., et al. Cancer immunotherapy with interleukin 12 and granulocyte-macrophage colony-stimulating factor-encapsulated microspheres: coinduction of innate and adaptive antitumor immunity and cure of disseminated disease. Cancer Res 62 (2002) 7254-7263
35. den Haan J.M., Lehar S.M., and Bevan M.J. CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo. J Exp Med 192 (2000) 1685-1696
36. Agrawal S., Agrawal A., Doughty B., Gerwitz A., Blenis J., Van Dyke T., et al. Cutting edge: different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos. J Immunol 171 (2003) 4984-4989
37. De Smedt T., Butz E., Smith J., Maldonado-Lopez R., Pajak B., Moser M., et al. CD8alpha(-) and CD8alpha(+) subclasses of dendritic cells undergo phenotypic and functional maturation in vitro and in vivo. J Leukoc Biol 69 (2001) 951-958
38. Maldonado-Lopez R., De Smedt T., Michel P., Godfroid J., Pajak B., Heirman C., et al. CD8alpha+ and CD8alpha-subclasses of dendritic cells direct the development of distinct T helper cells in vivo. J Exp Med 189 (1999) 587-592
39. Maldonado-Lopez R., De Smedt T., Pajak B., Heirman C., Thielemans K., Leo O., et al. Role of CD8alpha+ and CD8alpha-dendritic cells in the induction of primary immune responses in vivo. J Leukoc Biol 66 (1999) 242-246
40. Maldonado-Lopez R., Maliszewski C., Urbain J., and Moser M. Cytokines regulate the capacity of CD8alpha(+) and CD8alpha(-) dendritic cells to prime Th1/Th2 cells in vivo. J Immunol 167 (2001) 4345-4350
41. Pulendran B., Smith J.L., Caspary G., Brasel K., Pettit D., Maraskovsky E., et al. Distinct dendritic cell subsets differentially regulate the class of immune responses in vivo. Proc Natl Acad Sci U S A 96 (1999) 1036-1041
42. Rissoan M.C., Soumelis V., Kadowaki N., Grouard G., Briere F., de Waal Malefyt R., et al. Reciprocal control of T helper cell and dendritic cell differentiation. Science 283 (1999) 1183-1186
43. Boonstra A., Asselin-Paturel C., Gilliet M., Crain C., Trinchieri G., Liu Y.J., et al. Flexibility of mouse classical and plasmacytoid-derived dendritic cells in directing T helper type 1 and 2 cell development: dependency on antigen dose and differential toll-like receptor ligation. J Exp Med 197 (2003) 101-109